Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport
Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice
